N-((1-benzylpiperidin-3-yl)methyl)-n-(2-methoxyethyl)naphthalene-2-sulfonamide for the treatment of canine cognitive dysfunction and other forms of dementia in dogs

Use of a compound of formula (I)

• optionally in the form of a stereoisomer, such as enantiomer, or a mixture of at least two stereoisomers, such as at least two enantiomers, or a pharmaceutically acceptable salt, hydrate or solvate thereof, in the manufacture of a medicament for use in the treatment of canine cognitive dysfunction or other form of dementia in dog.

A pharmaceutical composition for use in the treatment of canine cognitive dysfunction or other form of dementia in dog, comprising a therapeutically effective a mound of formula (I)

• optionally in the form of a stereoisomer, such as enantiomer, or a mixture of at least two stereoisomers, such as at least two enantiomers, or a pharmaceutically acceptable salt, hydrate or solvate thereof.